TOI logo

TOI
Oncology Institute Inc (The)

779
Mkt Cap
$399.93M
Volume
2.45M
52W High
$4.88
52W Low
$2.02
PE Ratio
-7.10
TOI Fundamentals
Price
$4.00
Prev Close
$4.07
Open
$4.05
50D MA
$3.28
Beta
1.23
Avg. Volume
1.27M
EPS (Annual)
-$0.5445
P/B
-25.16
Rev/Employee
$784,288.61
$399.09
Loading...
Loading...

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available
Poll

Earnings Recap

• Reported GAAP EPS of -$0.02 up 90.48% YoY • Reported revenue of $147.44M up 41.22% YoY • The Oncology Institute anticipates Q2 2026 Adjusted EBITDA of -$1M to $1M, reflecting seasonal improvement. The company updated its 2026 Free Cash Flow guidance to $5 million to $15 million, an increase from previous guidance.

Bullish

The Oncology Institute delivered strong revenue growth, notably a 78% increase in Specialty Pharmacy revenue, and expanded its Medicare Advantage lives while preparing to launch a new provider portal.

Bearish

The Oncology Institute reported continued net losses and negative Adjusted EBITDA, alongside a decrease in cash and cash equivalents, while facing risks from competitive conditions and cybersecurity threats.

Latest TOI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.